The rapid proliferation of glucagon-like peptide-1 (GLP-1) receptor agonists has introduced unique and formidable challenges to the field of dentistry. In their latest pharmacology column, Drs. Donaldson and Goodchild explore the oral health implications of GLP-1 therapies, including delayed gastric emptying, medication-associated dry mouth, and emerging effects on bone and facial esthetics.

Stay updated on emerging evidence.